Table 2.
PTM | IFs | PTM enzyme (on) | PTM enzyme (off) | Tools for PTM analysis |
---|---|---|---|---|
Extensively studied | ||||
Phosphorylation | most IFs* | SAPKs, AKT1, PKC, Cdk1, Cdk5, other | PP1, PP2A | LC-MS; antibodies; phosphomutant transgenic mice; enzyme inhibitors |
Farnesylation | lamins | farnesyl transferase | Zmpste24 (via proteolysis) | Zmpste−/− mice, FTIs |
Ubiquitination | most IFs** | CHIP/STUB, Ubc3, UbcH5, Siah1, Trim32 | not known | LC-MS, in vitro ubiquitination; stress models; proteasome inhibitors |
Accumulating data | ||||
Sumoylation | lamins keratins vimentin |
Ubc9 | not known | LC-MS; in vitro sumoylation, SUMO antibodies |
Glycosylation | keratins neurofilaments vimentin |
OGT | O-GlcNAcase | LC-MS, transgenic mice (for example, K18-Gly-), antibodies (for example, NL6) |
Acetylation | keratins | not known | SIRT2 | LC-MS, pan-acetyllysine antibodies, acid-urea gels, deacetylase inhibitors |
Limited data | ||||
Transamidation | keratins | transglutaminases | none | in vitro and in vivo cross-linking analysis |
ADP ribosylation | desmin vimentin |
ADP-ribosyl transferase SpyA | not known | LC-MS, in vitro ribosylation |
phosphorylation of filensin, phakinin, and syncoilin is based on proteomic evidence
putative ubiquitination sites for most IFs have been identified by large scale proteomic studies